Loqtorzi (toripalimab-tpzi)
- Drug Name: Loqtorzi
- Generic Name: toripalimab
- Dosage Forms and Strengths: Injection: 240 mg/6 mL (40 mg/mL) solution in a single-dose vial
- Manufactured by: Coherus BioSciences, Inc.
LOQTORZI is a special medicine that helps fight a type of cancer in the nose and throat called nasopharyngeal carcinoma (NPC). Doctors use it in two different ways to help adults with this cancer. First, they give it along with two other medicines, cisplatin and gemcitabine, to people whose cancer has spread or come back after treatment. Second, they use LOQTORZI by itself for those whose cancer keeps growing after trying another treatment that included platinum. It helps stop the cancer from getting worse and gives hope to those who need more options for their treatment.
Recommended Dosage:
When used with cisplatin and gemcitabine, LOQTORZI is given through a vein (intravenously) every three weeks at a dose of 240 mg. If it’s used alone, the dosage is determined based on a person’s weight, and it’s given through a vein every two weeks at a rate of 3 mg per kilogram of body weight. For the first time, the medicine is infused slowly over 60 minutes. If everything goes well and there are no bad reactions during the first infusion, the following infusions can be a bit quicker, taking only 30 minutes. This helps make the treatment more convenient for patients.
- Immune System Reactions:
- Sometimes, the immune system can react to the medicine, which might affect different parts of the body like the lungs, stomach, liver, glands, kidneys, skin, or even organs after a transplant. Doctors need to keep a close watch and regularly check the liver, kidney, and thyroid functions. If these reactions happen, the medicine might need to be stopped, either temporarily or permanently, depending on how severe they are.
- Infusion Side Effects:
- While receiving the medicine, some people might have reactions during the infusion. If this happens, doctors might pause the infusion, slow it down, or stop it completely, depending on how serious it is.
- Transplant Complications:
- For people who had or are going to have a transplant involving someone else’s cells, there can be severe or fatal problems if they use this medicine.
- Risk of Harm to an Unborn Baby:
- For women who could get pregnant, this medicine might harm the baby. So, it’s important for them to use effective birth control to avoid getting pregnant during the treatment.
If you are considering the import of Loqtorzi (toripalimab-tpzi) to India, please be aware that Loqtorzi can be imported by patients or government hospitals solely in the name of the patients. The following documentation is essential for the successful import of this medication:
Required Documentation for Import:
- A valid prescription from a qualified medical practitioner.
- Diagnostic reports of the patient.
- Government-issued identification proof for the patient, as recognized by the Government of India.
Order Confirmation Process:
The order for Loqtorzi (toripalimab-tpzi) will be confirmed upon the receipt of the following documents:
- A valid prescription from a qualified doctor.
- An import permit, if applicable.
Availability of Loqtorzi (toripalimab-tpzi) in India:
Loqtorzi (toripalimab-tpzi) is classified as a prescription pharmaceutical drug. Consequently, it legally requires a medical prescription to be dispensed. Indian Pharma Network (IPN) specializes in facilitating the import of cancer medicines through named patient supply (NPS), ensuring transparency and authenticity by sourcing from reputable suppliers in the USA, Canada, Europe, and Australia.
Loqtorzi can be made accessible to patients, doctors, and hospitals in various cities across India, including but not limited to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune. To confirm an order, a valid prescription from a doctor and an import permit will be required.
IPN (Indian Pharma Network) is dedicated to facilitating the supply of Loqtorzi (toripalimab-tpzi) (prescription medicines) to locations both within India and worldwide, while adhering to relevant legal requirements.For inquiries regarding the price of Loqtorzi (toripalimab-tpzi) in India and to initiate the ordering process Our commitment lies in assuring quality and timely delivery to meet the healthcare needs of patients and medical professionals across the globe.
Indian Pharma Network is proficient in sourcing Loqtorzi (toripalimab-tpzi) from around the world and ensuring efficient delivery to patients. We provide worldwide access to the best available treatments and expedite prescription dispensing and delivery, with all prescriptions being dispensed and scrutinized by registered pharmacists before dispatching them to the patient’s address, exclusively from New Delhi, India.
What is Loqtorzi used for in cancer treatment?
Loqtorzi, also known as toripalimab, is specifically designed to help fight a type of cancer called nasopharyngeal carcinoma (NPC). It’s used in two ways: alongside cisplatin and gemcitabine for people whose cancer has spread or returned after treatment, and alone for those whose cancer continues to grow after previous platinum-based treatment. It helps slow down the cancer’s progress and offers hope to patients seeking alternative treatment options.
How is Loqtorzi given?
When combined with cisplatin and gemcitabine, Loqtorzi is administered through a vein every three weeks at a dose of 240 mg. If used alone, the dosage depends on a person’s weight, given through a vein every two weeks at 3 mg per kilogram of body weight. Initially, the medicine is infused slowly over 60 minutes. If the first infusion goes well without any bad reactions, subsequent infusions can be shorter, lasting only 30 minutes, making it more convenient for patients.
What are the key warnings and precautions while using Loqtorzi?
Loqtorzi can trigger reactions in the body’s immune system, affecting various organs like the lungs, stomach, liver, kidneys, glands, skin, and even transplanted organs. Doctors closely monitor liver, kidney, and thyroid functions and may need to stop the medicine if severe reactions occur. Additionally, some people might experience reactions during the infusion, which may lead to a pause, slower rate, or discontinuation based on the reaction’s seriousness. For individuals with or planning for a transplant, there might be severe complications if using this medicine. Women of childbearing potential should use effective birth control during treatment to avoid harming an unborn baby.
What documentation is needed to import Loqtorzi to India?
To import Loqtorzi to India, patients or government hospitals require specific documents: a valid prescription from a qualified medical practitioner, the patient’s diagnostic reports, and government-issued identification recognized by the Government of India. Import confirmation involves submitting a valid prescription and an applicable import permit.
How can one order Loqtorzi in India and its availability?
Loqtorzi is a prescription medicine and requires a valid doctor’s prescription for dispensation. Indian Pharma Network facilitates its import through named patient supply (NPS), ensuring authenticity and transparency. Interested parties inquiring about pricing, ordering, and delivery details can contact Indian Pharma Network through phone, toll-free number, or email, and the company ensures quality sourcing and timely delivery while adhering to legal requirements.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.